Retinitis Pigmentosa (RP) Completed Phase 1 / 2 Trials for Minocycline (DB01017)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02140164Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis PigmentosaTreatment